Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy

NCT00575523 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT00575523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00575523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2003
Completion date
January 31, 2008
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, respiratory arrest